In this online CME self-learning program:
Chronic constipation is a clinical condition comprised of myriad etiologies and subgroups that affects between 14 and 28 percent of the U.S. population. Not only is it prevalent, but it is also expensive; it results in anywhere between two and a half and seven million healthcare visits each year at a cost of $29 billion. In spite of its widespread impact, it is thought to be underreported due to social perceptions and lack of a clear-cut definition for constipation. Once the etiology of the complaint, or lack thereof, has been determined, the clinician may select an appropriate therapeutic approach. Initial management usually involves dietary changes, patient education, laxatives and enemas. If those treatment options fail, then manual disimpaction, suppositories, behavioral approaches including biofeedback, and surgical intervention may be considered. There are also a number of new medical therapies in clinical investigation or that have recently been approved whose place in therapy is still being determined.
This program has been designed to update healthcare professionals’ knowledge of chronic constipation and to optimize their competence in treating it. Agenda:
Introduction, Disclosures |
Challenges
|
Clinical Features of chronic constipation
|
Management strategies General measures Specific therapy Conventional therapy Treatment satisfaction in chronic constipation Dried plums: a randomized controlled trial Lubiprostone Linaclotide Prucalopride Probiotics
Take home points |
Healthcare professionals specializing in colon and rectal surgery, family medicine, internal medicine, gastroenterology, oncology, pain management, palliative care, primary care, proctology, and other clinicians who commonly treat patients suffering from chronic constipation.
This program is supported by an educational grant from Forest Laboratories
Release Date: August 26, 2013 -- Expiration Date: August 26, 2017
Faculty: Satish Rao,
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Satish Rao, MD, PhD has received grant funding and/or consulting income and/or speaker's bureau income from SmartPill Corp., Forest Laboratories, AMS, AstraZeneca, Ironwood Pharma., Asubiu Pharma.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevant financial disclosures.
Commercial Support Disclosure: This program is supported by an educational grant from Forest Laboratories
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.